Related Experiment Video
Updated: Jun 22, 2026

Pseudomonas aeruginosa Induced Lung Injury Model
Published on: October 29, 2014
ExoU-induced vascular hyperpermeability and platelet activation in the course of experimental Pseudomonas aeruginosa
Gloria-Beatriz S Machado1, Maria-Cristina de Assis, Robson Leão
1Departamento de Microbiologia, Imunologia e Parasitologia, Universidade do Estado do Rio de Janeiro, Brazil.
Abstract:
To address the question whether ExoU, a Pseudomonas aeruginosa cytotoxin with phospholipase A2 activity, can induce hemostatic abnormalities during the course of pneumosepsis, mice were instilled i.t. with the ExoU-producing PA103 P. aeruginosa or with a mutant obtained by deletion of the exoU gene. Control animals were instilled with sterile vehicle. To assess the role of ExoU in animal survival, mice were evaluated for 72 h. In all the other experiments, animals were studied at 24 h after infection. PA103-infected mice showed significantly higher mortality rate, lower blood leukocyte concentration, and higher platelet concentration and hematocrit than animals infected with the bacterial mutant, as well as evidences of increased vascular permeability and plasma leakage, which were confirmed by our finding of higher protein concentration in bronchoalveolar lavage fluids and by the Evans blue dye assay. Platelets from PA103-infected mice demonstrated features of activation, assessed by the flow cytometric detection of higher percentage of P-selectin expression and of platelet-derived microparticles as well as by the enzyme immunoassay detection of increased thromboxane A2 concentration in animal plasma. Histopathology of lung and kidney sections from PA103-infected mice exhibited evidences of thrombus formation that were not detected in sections of animals from the other groups. Our results demonstrate the ability of ExoU to induce vascular hyperpermeability, platelet activation, and thrombus formation during P. aeruginosa pneumosepsis, and we speculate that this ability may contribute to the reported poor outcome of patients with severe infection by ExoU-producing P. aeruginosa.
Insights
Pseudomonas aeruginosa cytotoxin ExoU causes hemostatic abnormalities, including platelet activation and thrombus formation, during pneumosepsis. This contributes to increased mortality and severe outcomes in infected patients.
Area of Science:
- Microbiology
- Pathophysiology
- Toxicology
Background:
- Pseudomonas aeruginosa is a significant opportunistic pathogen.
- Pneumosepsis is a severe lung infection with high mortality.
- ExoU is a cytotoxin produced by some P. aeruginosa strains, possessing phospholipase A2 activity.
Purpose of the Study:
- To investigate whether the P. aeruginosa cytotoxin ExoU induces hemostatic abnormalities during pneumosepsis.
- To assess the role of ExoU in the severity and outcome of P. aeruginosa-induced pneumosepsis in a mouse model.
Main Methods:
- Instillation of ExoU-producing P. aeruginosa (PA103) or an exoU mutant into the trachea of mice.
- Evaluation of animal survival, blood parameters (leukocytes, platelets, hematocrit), vascular permeability, and plasma leakage.
- Assessment of platelet activation markers (P-selectin, platelet-derived microparticles) and thromboxane A2 levels.
- Histopathological examination of lung and kidney tissues for thrombus formation.
Main Results:
- Mice infected with ExoU-producing P. aeruginosa exhibited higher mortality rates compared to those infected with the mutant.
- ExoU-infected mice showed increased vascular permeability, plasma leakage, platelet activation, and thromboxane A2 levels.
- Histopathology revealed thrombus formation in the lungs and kidneys of mice infected with ExoU-producing P. aeruginosa, but not in controls or mutant-infected groups.
Conclusions:
- ExoU is capable of inducing vascular hyperpermeability, platelet activation, and thrombus formation during P. aeruginosa pneumosepsis.
- These hemostatic abnormalities mediated by ExoU may contribute to the poor clinical outcomes observed in patients with severe infections caused by ExoU-producing P. aeruginosa.

